DeveloGen

DeveloGen is a biopharmaceutical company engaged in the discovery and development of novel therapeutic drugs for the treatment of metabolic disorders. The Company has a broad and innovative pipeline from lead discovery to phase III clinical development.

Contact Details: Marie-Curie-Str. 7 Goettingen 37079 Germany Tel: 49 (0)551-50 558 0 Fax: 49 (0)551-50 558 588 Email: info@develogen.com WWW: www.develogen.de/

Recent Publications by DeveloGen:
A novel substrate mimetic inhibitor of PKB/Akt inhibits prostate cancer tumor growth in mice by blocking the PKB pathway. We describe a novel, potent peptide substrate mimetic inhibitor of protein...	19th June, 2007	DeveloGen Israel Ltd., Kiryat Weizmann, Building 16, Rehovot, Israel.	Biochemistry. 2007 Apr 24;46(16):4716-24. Epub 2007 Mar 31. DOI Direct Link
Inhibition of GSK3 promotes replication and survival of pancreatic beta cells. Recent developments indicate that the regeneration of beta cell function...	1st June, 2007	DeveloGen AG, Marie-Curie-Strasse 7, Gottingen 37079, Germany.	J Biol Chem. 2007 Apr 20;282(16):12030-7. Epub 2007 Jan 22. DOI Direct Link
DiaPep277 preserves endogenous insulin production by immunomodulation in type 1 diabetes. DiaPep277 is an immunomodulatory peptide that arrests beta cell...	11th January, 2007	DeveloGen Israel Ltd., Kiryat Weizmann, Rehovot 76326, Israel.	Ann N Y Acad Sci. 2006 Oct;1079:340-4. DOI Direct Link
Obesity and related disorders--SMi's Second Annual Conference. DiaPep277 is an immunomodulatory peptide that arrests beta cell...	29th July, 2005	DeveloGen AG, Rudolf-Wissell Strasse 28, D-37079 Gottingen, Germany.	IDrugs. 2005 Apr;8(4):297-8.
Phenotype-first screening for the identification of novel drug targets. Modern drug discovery is predominantly a target-driven process, where...	13th July, 2005	DeveloGen AG, Rudolf-Wissell-Strasse 28, 37079 Gottingen, Germany.	Drug Discov Today. 2005 Feb 15;10(4):275-82. DOI Direct Link
→View more DeveloGen research publications.

Press Releases on DeveloGen:
A Non-Injectable Short-Acting Insulin for Type 1 Diabetes With Significantly Improved Efficacy Over Insulin Aspart Would Earn a Higher Patient Share in Europe Than in the United States	29th January, 2009	Decision Resources	MannKind's Technosphere Used in Conjunction With Insulin Glargine Will Earn Decision Resources' Clinical Gold Standard in 2012, According to a New Report from Decision Resources WALTHAM,
Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market	12th August, 2008	Decision Resources, Inc.	WALTHAM, Mass., Aug. 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the most significant
Life Sciences Day of DVC Deutsche Venture Capital – Highlights and	1st July, 2004	Dvc	Life Sciences Day of DVC Deutsche Venture Capital – Highlights and Trends in the Biotechno­logy-Sector in Germany 16. July 2004 III. Munich – The third Life Science Day of the DVC has taken
DEVELOGEN COMPLETES 19 MILLION EURO FINANCING ROUND	1st May, 2004	Develogen	DEVELOGEN COMPLETES 19 MILLION EURO FINANCING ROUND Goettingen, Germany, Rehovot, Israel - 17 May 2004 – DeveloGen AG, a biology-driven drug discovery company developing novel therapies for
DeveloGen receives R&D Funds for diabetic Complications Project	1st January, 1970	Develogen	DeveloGen receives R&D Funds for diabetic Complications Project Goettingen, November 9, 2004 – DeveloGen AG receives approval for funding from the BioChancePLUS Programme of the

BioNews Results for DeveloGen:
Scientists at TU Braunschweig and DeveloGen AG receive Phoenix Science Award 2009 for a publication in the fie	Pharmacy Choice:  Nov 9 2009 4:12PM Matching: develogen
Scientists at TU Braunschweig and DeveloGen AG receive Phoenix Science Award 2009 for a publication in the fie	Therapeutics Daily:  Nov 9 2009 11:02AM Matching: develogen

DeveloGen Clinical Trials:
Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

DeveloGen Patents:
US Patent No.	Title
7404952	Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis
7211563	Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis
7084244	Conformationally constrained backbone cyclized peptide analogs
7060679	Conformationally constrained backbone cyclized somatostatin analogs
7045592	Processes for coupling amino acids using bis-(trichloromethyl) carbonate
→View more DeveloGen patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 318 times since April 2007, the link to the organisation's website has been followed 34 times

Recent Search Terms used to find this page: waltham 7084244 | .

Search for more companies in Goettingen

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for DeveloGen